Wednesday, August 26, 2015 11:31:28 AM
Too bad that company cannot make public their financial expectations with this new company. Citing what the industry volume, does not mean a thing in regard to what Acculife will produce in the future. To people looking from the outside, there is not enough information given for them to make a quantifiable investment in this stock.
Also, if the deal has been completed, why was is not disclosed, the share impact of current shareholders in ECSL??? ( 1 for 1 ???) If we were getting any shares of the new company, this would have already been determined at signing of the contract, and should have been disclosed at time of signing announcement. I was very dissapointed as to the vaque contact of this PR - news continues to be of no interest to new investors in the open market.
Come on Ron, give us some real sales news that we can take to the bank - and get us the hell off of the Pinks !!!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM